Ashley Lulloff, 40, of Neenah, was arrested Thursday for operating while under the influence, 5th offense. Drug paraphernalia ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

Influenza is affecting hundreds of thousands of people in Japan and rising rapidly among that nation's population of 124.5 ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

In the ‘80s, researchers set out to test a medication called sildenafil citrate for treating high blood pressure and angina ...

A Virginia pharmacy owner will serve jail time for a generic medication scheme that caused $1.3 million in losses to the government, federal officials said. Randy Yost, 72, who owns Randy’s Gateway ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...